This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Albumin Is Predictive of 1-Year Mortality After Transcatheter Aortic Valve Replacement

Tuesday, November 27, 2018

Submitted by


Source Name: The Annals of Thoracic Surgery


Katherine R. Hebeler, Heike Baumgarten, John J. Squiers, Jordan Wooley, Benjamin D. Pollock, Cecile Mahoney, Giovanni Filardo, Brian Lima, J. Michael DiMaio

Hebeler and colleagues hypothesized that the inclusion of measures of frailty might improve the prediction of mortality one-year after transcatheter aortic valve replacement (TAVR). In 470 patients undergoing TAVR, sarcopenia was measured and frailty was assessed preoperatively by gait speed, hand grip strength, serum albumin, and Katz activities of daily living. The addition of both sarcopenia and frailty measures to the STS Predicted Risk of Mortality improved the predictive capacity of the model (area under the curve of 0.61 versus 0.52), and albumin was the only marker that was significantly associated with an increased one-year mortality risk.

Add comment

Log in or register to post comments